Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
US FDA Sets Stricter Approval Standards for COVID-19 Vaccine Boosters; Moderna Soars 6%
Recommend 3 Positive 5 Negative 1 |
||||
|
||||
|
The U.S. Food and Drug Administration (FDA) announced new regulatory guidelines for COVID-19 vaccine boosters on Tuesday, establishing stricter approval standards for Americans. The FDA hopes to see new clinical trials proving that COVID-19 vaccines remain safe and effective before approving them for healthy adults and children. This will be a costly new requirement for pharmaceutical companies and may limit the number of new vaccines administered each year. The news bolstered vaccine stocks, with Moderna (MRNA.US) up 6%, and BioNTech (BNTX.US) and Novavax (NVAX.US) up 1-2%. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
